NCT05963737

Brief Summary

Pressure support ventilation (PSV) is an assistant mechanical ventilation mode, that is widely implemented in mechanical ventilation treatment but there are no exact guidelines to guide PS setting. Traditional PS setting strategy (VT/PBW 6-8ml/kg and RR 20-30 breaths/min)has risks of excessive or insufficient assistance. Inspiratory muscle pressure index (PMI) is a noninvasive respiratory mechanical indicator and is available at the bedside. PMI was correlated with inspiratory effort and has the potential ability to predict low inspiratory effort and high inspiratory effort. The primary objective of this study is to investigate the clinical validity of a PMI-guided PS setting strategy. Specifically, the investigators aim to evaluate its impact on inspiratory effort as well as its potential for lung and diaphragm protection. Additionally, the investigators seek to assess the effect of this ventilation strategy on mechanical ventilation outcomes while evaluating the feasibility of our trial protocol.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 1, 2023

Completed
26 days until next milestone

First Posted

Study publicly available on registry

July 27, 2023

Completed
5 days until next milestone

Study Start

First participant enrolled

August 1, 2023

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

January 9, 2025

Status Verified

July 1, 2024

Enrollment Period

2.3 years

First QC Date

July 1, 2023

Last Update Submit

January 8, 2025

Conditions

Keywords

pressure support ventilationinspiratory effortinspiratory muscle pressure index

Outcome Measures

Primary Outcomes (1)

  • The proportion of conditions in the range of normal inspiratory effort per patient

    the time from the start of PSV mode to the successful weaning of the ventilated patients

    up to 48 hours

Secondary Outcomes (9)

  • The duration of mechanical ventilation

    up to 28 days

  • Tracheostomy rate

    up to 28 days

  • Reintubation rate

    up to 28 days

  • Diaphragm thickness (Tdi)

    up to 28 days

  • Diaphragm thicken fraction (TFdi)

    up to 28 days

  • +4 more secondary outcomes

Study Arms (2)

Experimental arm

EXPERIMENTAL

The initial PS level is set up based on VT/PBW (6-8ml/kg) and RR (20-30 breaths/min) when patients are enrolled in the experimental arm. The following steps need to be repeated every 2 hours for 48 hours. Step 1: 3 times short EIOs (2-3s) are performed. At least 1 minute between each occlusion. PMI is calculated as the mean value of 3 measured values. Step 2: Clarify whether PMI is in the target range (PMI 0-2cmH2O). If yes, keep this PS level. If not, implement step 3. Step 3: A downward or upward PS setting adjustment is performed at a 1cmH2O interval. Every PS level is maintained for 3-5 minutes. PMI is measured again and step 3 is repeated until the PMI target is reached. Step 4: supplemental adjustment: PS setting needs to be returned to the previous level if the patient presents the following signs: VT \< 4 ml/Kg, RR \> 35 breaths/min, respiratory acidosis, respiratory distress, VT \> 10ml/Kg, Pplat \> 30 cmH2O, respiratory alkalosis.

Procedure: PS setting strategy in pressure-support ventilated patients

Control arm

NO INTERVENTION

Patients randomized to the control arm need to continue to accept the traditional ventilation strategy which is VT/PBW (6-8ml/kg) and RR (20-30breaths/min) guide PS setting.

Interventions

Use PMI guide PS setting in pressure-supported ventilated patients and keep PMI within the target range (0-2cmH2O).

Experimental arm

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients under PSV
  • Predicted ventilated time of more than 48 hours.

You may not qualify if:

  • Age less than 18 years old;
  • Known pregnancy;
  • BMI\>35kg/m2;
  • Brain-stem or cervical cord injury;
  • Known or clinically suspected elevated intracranial pressure (ICP\>18 mmHg);
  • Nervus phrenicus or diaphragm injury;
  • Broncho-pleural fistula;
  • Chronic obstructive pulmonary disease (COPD);
  • Pressure support ventilated time more than 48 hours before randomization.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Beijing Tiantan Hospital

Beijing, Beijing Municipality, 100071, China

RECRUITING

Related Publications (1)

  • Gao R, Yang YL, Zhang L, Miao MY, Zhou JX. Use of pressure muscle index to guide pressure support ventilation setting: a study protocol and statistical plan for a prospective randomised controlled proof-of-concept trial. BMJ Open. 2024 Aug 3;14(8):e082395. doi: 10.1136/bmjopen-2023-082395.

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

July 1, 2023

First Posted

July 27, 2023

Study Start

August 1, 2023

Primary Completion

December 1, 2025

Study Completion

December 31, 2025

Last Updated

January 9, 2025

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

Locations